Hindawi Publishing Corporation Journal of Obesity Volume 2011, Article ID 179674, 18 pages doi:10.1155/2011/179674 Review Article Pharmacotherapies for Obesity: Past, Current,…

1. ANEMIA Prof. M A Bakr (MD) Urology & Nephrology Center Mansoura University - Egypt 2. I. Anemia and kidney II. Biosimilars III. Recommendations AGENDA 3. I. Anemia…

www.medscape.com Blood Pressure and Diabetes Vicious Twins Neel P Chokshi, Ehud Grossman, Franz H Messerli Heart. 2013;99(8):577-585. Epidemiology Hypertension (HTN) and…

1. DIABETES MELLITUS Rabia Tahir, Pharm.D. Department of Veterans Affairs NYHHCS 2. Objectives Identify the development of signs and symptoms of diabetes mellitus. List diagnostic…

1. Nutritional approaches to managing cholesterol and CVD. Key messages from the research. Sophie Tully BSc MSc DIPPT 2. What is CVD? Cardiovascular disease (CVD) is a general…

1. Statin Combinations Is there a rationale ? 2. Statin Combinations : A key in search of a lock ! A solution in search of a problem ! • LDLC at goal, but residual risk…

1. Beyond Framingham: Contemporary Evolution ofIndividualized Coronary Heart Disease Risk Assessment Jeffrey L. Anderson, MDProfessor of Medicine, University of Utah Associate…

1.   2.   3. PRESENATATION BY DR MISBAHUL FERDOUS MBBS(USTC) FMD (USTC) PGT (CARDIOLOGY)NICVD.DHAKA PUBLICATION- 1(ORIGINALARTICLE) METABOLIC SYNDROMEAND ACUTE STELEVATIONMIINHOSPITAL…

Slide 1Effect of Rosuvastatin Versus Placebo on Cardiovascular Outcomes in Patients with End-Stage Renal Disease on Hemodialysis – Results of the AURORA Study Bengt Fellström…

Slide 1 Slide 2 Lipid Management Standard and Advanced Preview of ATP-IV Thomas G. Allison, PhD, MPH Mayo Clinic Rochester, MN USA Slide 3 DISCLOSURE Relevant Financial Relationship(s)…